BELGIUM: European Union research team maps protein important for the development of new medicines
October 1st, 2007
Keith Nuthall
Brussels
A EUROPEAN Union (EU)-funded research team, working with scientists from the USA's Stanford University and the European synchrotron radiation facility, in Grenoble, has mapped the structure of a protein which plays a crucial role in spreading diseases around the body. This recombinant G protein-coupled receptor is a "potentially very important target for future medicines" development, because of this biological function, said a European Commission note. The EU executive has now also announced it will spend Euro 11 million each on ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.